[Modified lipoproteins and atherogenesis].
Fruchart
J C
JC
Sauzières
J
J
Plancke
M O
MO
Luc
G
G
Clavey
V
V
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000378:metabolism; D053419:Lipoproteins, IDL; D008077:Lipoproteins, LDL / Q000097:blood* / Q000378:metabolism; D011817:Rabbits; D012307:Risk Factors; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D008074:Lipoproteins; D053419:Lipoproteins, IDL; D008077:Lipoproteins, LDL; D014810:Vitamin E
Lipoprotéines modifiées et athérogenèse.